证券日报网讯九安医疗（002432）10月17日在互动平台回答投资者提问时表示，公司截至2025年10月10 日，股东人数约7.21万户。 ...

10月16日，九安医疗涨1.29%，成交额5.37亿元。两融数据显示，当日九安医疗获融资买入额6385.63万 元，融资偿还5510.12万元，融资净买入875.51万元。截至10月16日，九安医疗融资融券余额合计12.11 亿元。 融券方面，九安医疗10月16日融券偿还2000.00股，融券卖出5000.00股，按当日收盘价计算，卖出金额 20.39万元；融券余量24.43万股，融券余额995.81万元，超过近一年90%分位水平，处于高位。 资料显示，天津九安医疗电子股份有限公司位于天津市南开区南开工业园雅安道金平路3号，成立日期 1995年8月22日，上市日期2010年6月10日，公司主营业务涉及家用医疗健康电子产品的研发、生产和销 售。主营业务收入构成为：iHealth系列产品78.56%，ODM/OEM产品7.72%，互联网医疗产品及服务 6.57%，新零售业务5.03%，传统硬件产品1.46%，其他0.66%。 截至9月19日，九安医疗股东户数7.20万，较上期减少1.50%；人均流通股6582股，较上期增加1.53%。 2025年1月-6月，九安医疗实现营业收入7.65亿元，同比减少43.35%； ...

九安医疗（002432.SZ）10月17日在投资者互动平台表示，公司2025年三季度报告预约披露时间为2025 年10月25日，2025年前三季度经营及财务情况届时详见定期报告。敬请关注。 （记者 王晓波） 每经AI快讯，有投资者在投资者互动平台提问：三季度与去年同期比较，业绩是增长还是减少？是不 是要发一个自主性业绩披露预告？ ...

公司 2024 年员工持股计划管理委员会委员施向健先生因个人原因，申请辞 去管理委员会委员职务。根据公司《2024 年员工持股计划管理办法》的相关规 定，本次持有人会议同意补选马志国先生为公司 2024 年员工持股计划管理委员 会委员，任期与本次员工持股计划存续期一致。 马志国先生未在公司担任董事、监事、高级管理人员职务，未在公司第一大 股东单位担任职务，与持有公司 5%以上股东、实际控制人、公司董事、监事、 高级管理人员不存在关联关系。 证券代码：002432 证券简称：九安医疗 公告编号：2025-080 天津九安医疗电子股份有限公司 2024年员工持股计划第二次持有人会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 天津九安医疗电子股份有限公司（以下简称"公司"）于 2025 年 10 月 15 日 在公司会议室以现场结合通讯方式召开 2024 年员工持股计划第二次持有人会议。 本次会议通知已于 2025 年 10 月 11 日以通讯方式发出。本次会议由公司 2024 年员工持股计划管理委员会召集，由管理委员会主任张飞先生主持。本次应参会 持 ...

Core Viewpoint - The Shanghai Composite Index closed at 3916.23 points, above the annual line, with a slight increase of 0.10% on the day, and the total trading volume of A-shares reached 1,948.66 billion yuan [1][2] Group 1: Market Performance - As of the latest close, 19 A-shares have surpassed the annual line, indicating positive market sentiment [1] - The stocks with the largest deviation rates include Shenglong Co., Changshan Beiming, and Youlide, with deviation rates of 9.96%, 3.76%, and 2.52% respectively [1] - The total trading volume for A-shares today was 1,948.66 billion yuan, reflecting active market participation [1] Group 2: Individual Stock Highlights - Shenglong Co. (603178) saw a daily increase of 10.00% with a turnover rate of 9.13% and a latest price of 21.45 yuan, resulting in a deviation rate of 9.96% [1] - Changshan Beiming (000158) increased by 9.98% with a turnover rate of 9.68%, latest price at 24.57 yuan, and a deviation rate of 3.76% [1] - Youlide (688628) experienced a 4.23% increase, with a turnover rate of 2.91%, latest price of 36.22 yuan, and a deviation rate of 2.52% [1]

Market Overview - The Shanghai Composite Index is at 3916.86 points, above the annual line, with a change of 0.12% [1] - The total trading volume of A-shares is 909.4 billion yuan [1] Stocks Breaking Annual Line - A total of 20 A-shares have surpassed the annual line today, with notable stocks including: - Shenglong Co., Ltd. (603178) with a deviation rate of 9.96% - Lege Co., Ltd. (300729) with a deviation rate of 2.14% - Jinguang Co., Ltd. (300510) with a deviation rate of 1.75% [1] Deviation Rate Rankings - The following stocks have the highest deviation rates after breaking the annual line: - Shenglong Co., Ltd. (603178): Today's change of 10.00%, turnover rate of 4.72%, latest price at 21.45 yuan [1] - Lege Co., Ltd. (300729): Today's change of 4.01%, turnover rate of 4.10%, latest price at 15.58 yuan [1] - Jinguang Co., Ltd. (300510): Today's change of 2.00%, turnover rate of 5.62%, latest price at 4.60 yuan [1] Stocks with Smaller Deviation Rates - Stocks with smaller deviation rates that have just crossed the annual line include: - Changjiang Electric Power (600900): Today's change of 0.36%, latest price at 28.03 yuan, deviation rate of 0.01% [2] - Beiqi Blue Valley (600733): Today's change of 3.05%, latest price at 8.11 yuan, deviation rate of 0.03% [2] - Hongcheng Environment (600461): Today's change of 0.22%, latest price at 9.10 yuan, deviation rate of 0.05% [2]

Core Insights - On October 16, 17 companies announced a total of 17 stock repurchase updates, indicating a significant activity in the market [1] Group 1: First Disclosure of Repurchase Plans - Three companies disclosed their stock repurchase plans for the first time, with proposed repurchase amounts of up to 400 million yuan, 150 million yuan, and 100 million yuan respectively for Hengmingda, Qizhong Technology, and Kangchen Pharmaceutical [1] Group 2: Approval of Repurchase Plans by Shareholders - Five companies had their repurchase plans approved by shareholder meetings, with the highest proposed repurchase amounts being 150 million yuan for Fenghuo Communication, 70 million yuan for Shaanxi Jinye, and 10 million yuan for Youkede-W [1] Group 3: Progress of Implemented Repurchase Plans - Four companies reported on the progress of their repurchase plans, with the highest repurchase amounts being 37.86 million yuan for Jiuan Medical, 11.19 million yuan for Intercontinental Oil and Gas, and 3.09 million yuan for Jiansheng Group [1] Group 4: Completed Repurchase Plans - Five companies completed their repurchase plans, with the highest completed amounts being 797 million yuan for Zhongwei Co., 200 million yuan for Shuangta Food, and 7.5177 million yuan for Shapais [1]

证券日报网讯10月15日晚间，九安医疗（002432）发布公告称，2025年10月15日，公司首次通过股份回 购专用证券账户以集中竞价方式回购公司股份946，400股，占公司目前总股本0.20%。 ...

Core Viewpoint - Tianjin Jiuan Medical Electronics Co., Ltd. has initiated its share repurchase plan, marking a significant step in its financial strategy [1][2]. Group 1: Share Repurchase Details - On October 15, 2025, the company completed its first share repurchase, acquiring 946,400 shares, which represents 0.20% of its total share capital, for a total transaction amount of 37.86 million yuan [1][2]. - The board approved a share repurchase plan on October 13, 2025, with a total funding of no less than 300 million yuan and no more than 600 million yuan, and a maximum repurchase price of 53.5 yuan per share [2]. Group 2: Compliance and Future Disclosures - The company will disclose the share repurchase details on the trading day following the repurchase, in accordance with regulatory guidelines [3]. - Jiuan Medical has committed to not conducting repurchases during periods that could affect stock prices due to significant events, adhering to regulations set by the China Securities Regulatory Commission and Shenzhen Stock Exchange [3].

格隆汇10月15日丨九安医疗(002432.SZ)公布，2025年10月15日，公司首次通过股份回购专用证券账户 以集中竞价方式回购公司股份946,400股，占公司目前总股本0.20%，最高成交价为40.10元/股，最低成 交价为39.83元/股，成交金额37,860,778.00元（不含交易费用）。本次回购符合相关法律法规的要求， 符合既定的回购股份方案。 ...